1. EPWORTH Knowedge Bank
  2. Academic & Clinical
  3. Radiation Oncology
Please use this identifier to cite or link to this item: http://hdl.handle.net/11434/218
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBowden, Patricken
dc.contributor.otherWhite, Rohenen
dc.contributor.otherKhor, Richarden
dc.contributor.otherBressel, Mathiasen
dc.contributor.otherDuchesne, Gillianen
dc.contributor.otherWilliams, Scotten
dc.contributor.otherTai, Keen Hunen
dc.contributor.otherForoudi, Farshaden
dc.date2014-10en
dc.date.accessioned2015-06-10T04:14:26Zen
dc.date.available2015-06-10T04:14:26Zen
dc.date.issued2015-01en
dc.identifier.citationClin Oncol (R Coll Radiol). 2015 Jan;27(1):16-21.en
dc.identifier.issn0936-6555en
dc.identifier.urihttp://hdl.handle.net/11434/218en
dc.description.abstractAIMS: There are limited outcome data after radiotherapy treatment for clinically localised, castration-resistant prostate cancer. We report our single institution experience on patient outcomes in this group using high-dose palliative radiotherapy (HDPRT). MATERIALS AND METHODS: A retrospective review of patient hospital records was conducted in prostate cancer patients treated with palliative intent radiotherapy and restricted to those who had castration-resistant disease, no evidence of regional or distant disease and who received a local radiotherapy dose equivalent to 40 Gy or greater.en
dc.publisherScience Direct / Elsevieren
dc.subjectRadiation Oncology, Epworth Healthcare, Melbourne, VIC, Australiaen
dc.subjectProstate Canceren
dc.subjectRadiation Oncologyen
dc.subjectHigh-Dose Palliative Radiotherapyen
dc.subjectHDPRTen
dc.subjectRadiotherapyen
dc.subjectCastration-Resistant Prostate Canceren
dc.subjectPalliativeen
dc.titleEfficacy of high-dose palliative radiotherapy for localised, castration-resistant prostate cancer.en
dc.typeJournal Articleen
dc.identifier.doi10.1016/j.clon.2014.09.013en
dc.identifier.journaltitleClinical Oncology (The Royal College of Radiologists)en
dc.description.pubmedurihttp://www.ncbi.nlm.nih.gov/pubmed/25445554en
dc.description.affiliatesCentre for Biostatistics and Clinical Trials, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.en
dc.description.affiliatesDepartment of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australiaen
dc.description.affiliatesSir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.en
dc.description.affiliatesDepartment of Biochemistry, Monash University, Melbourne, VIC, Australiaen
dc.description.affiliatesDepartment of Medical Radiations, Monash University, Melbourne, VIC, Australiaen
dc.type.studyortrialRetrospective Reviewsen
dc.type.contenttypeTexten
Appears in Collections:Cancer Services
Radiation Oncology
UroRenal, Vascular

Files in This Item:
There are no files associated with this item.
Show simple item record


Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.